TrialClinical pharmacology and therapeutics2025

Safety, Pharmacokinetics, and Pharmacodynamics of a First-in-Class ClC-1 Inhibitor to Enhance Muscle Excitability: Phase I Randomized Controlled Trial.

Titia Q Ruijs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.